At Geistek Pharmaceuticals, our Language Services division specializes in providing tailored translation programs to meet the unique requirements of your study or company. We understand the critical role that accurate and culturally appropriate translations play in the success of clinical research.
With a global network of over 2,500 trusted medical and clinical translators, including linguistic validation specialists, we have the flexibility and scalability to support translation needs in over 300 languages across clinical research locations worldwide.
Quality is of utmost importance to us. Our Language Services division maintains an effective quality management system to ensure the delivery of high-quality translations. We have rigorous quality assurance processes in place to meet industry standards and regulatory requirements, guaranteeing accuracy and consistency in our translations.
By partnering with Geistek Pharmaceuticals for your language services needs, you can benefit from:
Contact our Language Services team at Geistek Pharmaceuticals today to discuss your translation requirements. We are committed to providing you with high-quality translations that save you time, reduce risk, and enhance the overall quality of your study or company’s communication.
INTRODUCTION Tecartus is a new advanced therapy approved to treat adults with mantle cell lymphoma (MCL)¹. This disease is a lymphatic system cancer. Specifically, it
INTRODUCTION Kymriah (Novartis) is an advanced therapy medicine that belongs to the gene therapyproduct category. It is approved for B-cell acute lymphoblastic leukemia (ALL) in
INTRODUCTION ¹. CARVYKTI™ (ciltacabtagene autoleucel – Johnson & Johnson) was approved by the U.S. Food and Drug Administration (FDA) in February 2022 for the treatment
